IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Historical Portfolio Holders from Q3 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 1.500% 6/1
Principal, excl. options Q2 2024
200M
Holdings value Q2 2024
$188M
Value change Q2 2024
-$1.54M
Grand Portfolio weight change Q2 2024
0%
Number of holders
19
Number of buys Q2 2024
9
Number of sells Q2 2024
-13
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q2 $200M $188M -$1.54M $0.94 19
2024 Q1 $197M $201M -$4.54M $1.01 26
2023 Q4 $198M $215M -$57.8M $1.08 23
2023 Q3 $254M $235M +$47.1M $0.98 21
2023 Q2 $195M $199M -$3.82M $1.02 17
2023 Q1 $199M $200M +$3.86M $1.00 23
2022 Q4 $193M $212M +$3.26M $1.09 25
2022 Q3 $172M $176M -$19.1M $1.02 23
2022 Q2 $191M $206M -$3.26M $1.08 20
2022 Q1 $194M $228M -$1.41M $1.18 19
2021 Q4 $196M $222M -$9.18M $1.14 19
2021 Q3 $198M $243M +$25.8M $1.21 19
2021 Q2 $177M $211M +$8.63M $1.20 18
2021 Q1 $170M $192M -$4.71M $1.13 17
2020 Q4 $174M $196M +$1.16M $1.13 17
2020 Q3 $174M $170M +$170M $0.98 18